December 19, 2011 -- Beijing SL Pharmaceutical will establish a JV in Delaware with Lin Chai. The JV, which will be called Diapin Therapeutics, will focus on R&D for prevention or cure of diabetes. Beijing SL Pharma will invest $2 million in the JV for a 21% stake, while Lin Chai will contribute its Diapin project for the remaining 79%. More details....
Stock Symbol: (SHE: 002038)
